| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |